Objective To assess the safety and efficacy of rituximab in a randomized, double‐blind,
placebo‐phase trial in adult and pediatric myositis patients. Methods Adults with refractory …

Objectives: There is a known association between myositis and cancer. The risk is greater in
dermatomyositis (DM) than polymyositis (PM), although reliable methods to predict cancer …

Objective To describe the demographic, clinical, and laboratory features and natural history
of patients with systemic sclerosis sine scleroderma (ssSSc), and to compare them with …

Objective To determine the long‐term outcome and associated clinical, serologic, and
pathologic features in a cohort of patients with connective tissue disease (CTD) and the anti–…

Objective To compare the cumulative survival and event free survival in patients with Jo-1
versus non-Jo-1 anti-tRNA synthetase autoantibodies (anti-synAb). Methods Anti-synAb …

Objective To assess the efficacy of tacrolimus in patients with anti–aminoacyl–transfer RNA
synthetase (anti‐aaRS)–associated interstitial lung disease (ILD) and idiopathic …

Objective Previous case series have examined the relationship between anti–Jo‐1 antibody
levels and myositis disease activity, demonstrating equivocal results. Using enzyme‐linked …

Objective To investigate correlations between serum levels of topoisomerase I–specific antibody
(anti–topo I) and clinical features of systemic sclerosis (SSc), including disease severity …

Objective To examine the association of skin thickness progression rate (STPR) with mortality,
and as a predictor of future internal organ involvement in an inception cohort of diffuse …

Objective To compare anti‐Th/To–positive and anticentromere antibody (ACA)–positive
patients with limited cutaneous systemic sclerosis (lcSSc). Methods We reviewed the medical …